Browse > Article
http://dx.doi.org/10.5487/TR.2008.24.4.273

Noninvasive Monitoring of Bleomycin-induced Lung Injury in Rats Using Pulmonary Function Test  

Yang, Mi-Jin (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Yang, Young-Su (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Kim, Yong-Bum (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Cho, Kyu-Hyuk (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Heo, Jeong-Doo (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Lee, Kyu-Hong (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Song, Chang-Woo (Division of Inhalation Toxicology, KIT Jeongeup Campus)
Publication Information
Toxicological Research / v.24, no.4, 2008 , pp. 273-280 More about this Journal
Abstract
The single intratracheal instillation (ITI) of bleomycin (BLM) is a widely used method for inducing experimental pulmonary fibrosis in rat model. In the present study, pulmonary function tests (PFTs) of tidal volume ($V_T$), minute volume ($V_M$), and respiratory frequency ($F_R$) have been applied to study their possibility as a tool to monitor the progress of BLM-induced lung injury in rat model. Rats were treated with a single ITI of BLM (2.5 mg/kg) or saline (control). Animals were euthanized at 3, 7, 14, 21, and 28 days post-ITI. Lung toxicity effects were evaluated by inflammatory cell count, lactate dehydrogenase (LDH) activity in the bronchoalveolar lavage fluid (BALF), and light microscopic examination of lung injury. The PFT parameters were measured immediately before the animals were sacrificed. BLM treatment induced significant cellular changes in BALF-increase in number of total cells, neutrophils, and lymphocytes along with sustained increase in number of macrophages compared to the controls at days 3, 7, and 14. BALF LDH level was significantly increased compared to that in the controls up to day 14. On day 3, infiltration of neutrophils was observed in the alveolar spaces. These changes developed into marked peribronchiolar and interstitial infiltration by inflammatory cells, and extensive thickening of the interalveolar septa on day 7. At 14, 21, and 28 days, mild peribronchiolar fibrosis was observed along with inflammatory cell infiltration. The results of PFT show significant consistencies compared to the results of other toxicity tests. These data demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days post-ITI of BLM based on the observation of fibrosis at 14, 21, and 28 days. Further, the progress of lung injury can be traced by monitoring the PFT parameters of $F_R$, $V_T$, and $V_M$.
Keywords
Pulmonary function; Respiratory frequency; Tidal volume; Minute volume; Bleomycin; Animal model; Noninvasive monitoring; Lung injury;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Antoniou, K.M., Ferdoutsis, E. and Bouros, D. (2003). Interferons and their application in the diseases of the lung. Chest, 123, 209-216   DOI   ScienceOn
2 El-Medany, A., Hagar, H.H., Moursi, M., At Muhammed, R., El-Rakhawy, F.I. and El-Medany, G. (2005). Attenuation of bleomycin-induced lung fibrosis in rats by mesna. Eur. J. Pharmacol., 509, 61-70   DOI   ScienceOn
3 Gharaee-Kermani, M. and Phan, S.H. (2005). Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr. Pharm. Des., 11, 3943- 3971   DOI
4 Gharaee-Kermani, M., Ullenbruch, M. and Phan, S.H. (2005). Animal models of pulmonary fibrosis. Methods Mol. Med., 117, 251-259
5 Mason, R.J., Schwarz, M.I., Hunninghake, G.W. and Musson, R.A. (1999). NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am. J. Respir. Crit. Care. Med., 160, 1771- 1777   DOI   ScienceOn
6 Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M. (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell. Biol., 40, 362-382   DOI   ScienceOn
7 Spond, J., Billah, M.M., Chapman, R.W., Egan, R.W., Hey, J.A., House, A., Kreutner, W. and Minnicozzi, M. (2004). The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats. Pulm. Pharmacol. Ther., 17, 133-140   DOI   ScienceOn
8 Zhang, K., Gharaee-Kermani, M., McGarry, B. and Phan, S. H. (1994b). In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab. Invest., 70, 192-202
9 Lazenby, A.J., Crouch, E.C., McDonald, J.A. and Kuhn, C. 3rd (1990). Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am. Rev. Respir. Dis., 142, 206-214   DOI   ScienceOn
10 Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P. and Vassalli, P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature, 344, 245-247   DOI   ScienceOn
11 Kolb, M., Margetts, P.J., Galt, T., Sime, P.J., Xing, Z., Schmidt, M. and Gauldie, J. (2001). Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am. J. Respir. Crit. Care. Med., 163, 770-777   DOI   ScienceOn
12 Iraz, M., Erdogan, H., Kotuk, M., Yagmurca, M., Kilic, T., Ermis, H., Fadillioglu, E. and Yildirim, Z. (2006). Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol. Res., 53, 310-316   DOI   ScienceOn
13 Nathan, S.D., Shlobin, O.A., Ahmad, S., Urbanek, S. and Barnett, S.D. (2007). Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest., 131, 657-663   DOI   ScienceOn
14 Gross, T.J. and Hunninghake, G.W. (2001). Idiopathic pulmonary fibrosis. N. Engl. J. Med., 345, 517-525   DOI   ScienceOn
15 Jordana, M., Dolovich, M., Irving, L.B., Tomioka, M., Befus, D., Gauldie, J. and Newhouse, M.T. (1988). Solute movement across the alveolar-capillary membrane after intratracheally administered bleomycin in rats. Am. Rev Respir. Dis., 138, 96-100   DOI   ScienceOn
16 Karmouty-Quintana, H., Cannet, C., Zurbruegg, S., Ble, F.X., Fozard, J.R., Page, C.P. and Beckmann, N. (2007). Bleomycin- induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI. J. Magn. Reson. Imaging., 26, 941-949   DOI   ScienceOn
17 Sakanashi, Y., Takeya, M., Yoshimura, T., Feng, L., Morioka, T. and Takahashi, K. (1994). Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP- 1. J. Leukoc. Biol., 56, 741-750   DOI
18 Yang, M.J., Kim, J.S., Yang, Y.S., Cho, J.W., Chio, S.B., Chung, Y.H., Kim, Y.B., Cho, K.H., Lim, C.W., Kim, C.Y. and Song, C.W. (2008). Pulmonary toxicity and recovery from inhalation of manual metal arc stainless steel welding fume in rats. Toxicol. Res., 24, 119-127   DOI   ScienceOn
19 Martinez, F.J. and Flaherty, K. (2006). Pulmonary function testing in idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc., 3, 315-321   DOI   ScienceOn
20 Ashcroft, T., Simpson, J.M. and Timbrell, V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41, 467-470   DOI
21 Zhang, H.Y., Gharaee-Kermani, M., Zhang, K., Karmiol, S. and Phan, S.H. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin- induced pulmonary fibrosis. Am. J. Pathol., 148, 527- 537
22 Kuwano, K., Hagimoto, N. and Hara, N. (2001). Molecular mechanisms of pulmonary fibrosis and current treatment. Curr. Mol. Med., 1, 551-573   DOI
23 Zhang, K., Gharaee-Kermani, M., Jones, M.L., Warren, J.S. and Phan, S.H. (1994a). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol., 153, 4733-4741
24 Cortijo, J., Cerda-Nicolas, M., Serrano, A., Bioque, G., Estrela, J.M., Santangelo, F., Esteras, A., Llombart-Bosch, A. and Morcillo, E.J. (2001). Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur. Respir. J., 17, 1228-1235   DOI   ScienceOn
25 Gharaee-Kermani, M., Hu, B., Phan, S.H. and Gyetko, M.R. (2008). The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy. Expert. Opin. Investig. Drugs., 17, 905-916   DOI   ScienceOn
26 Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K. and Iwamoto, I. (1999). Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest., 104, 5-11   DOI   ScienceOn
27 Antonini, J.M., Taylor, M.D., Millecchia, L., Bebout, A.R. and Roberts, J.R. (2004). Suppression in lung defense responses after bacterial infection in rats pretreated with different welding fumes. Toxicol. Appl. Pharmacol., 200, 206-218   DOI   ScienceOn
28 Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W. and Breuer, R. (2002). Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol., 83, 111-119   DOI   ScienceOn
29 Okada, T., Sugie, I. and Aisaka, K. (1993). Effects of gammainterferon on collagen and histamine content in bleomycin- induced lung fibrosis in rats. Lymphokine Cytokine Res., 12, 87-91
30 Seagrave, J., Campen, M.J., McDonald, J.D., Mauderly, J.L. and Rohr, A.C. (2008). Oxidative stress, inflammation, and pulmonary function assessment in rats exposed to laboratory-generated pollutant mixtures. J. Toxicol. Environ. Health A, 71, 1352-1362   DOI   ScienceOn
31 Lynch, J.P., 3rd, White, E. and Flaherty, K. (2001). Corticosteroids in idiopathic pulmonary fibrosis. Curr. Opin. Pulm. Med., 7, 298-308   DOI
32 Tzurel, A., Segel, M.J., Or, R., Goldstein, R.H. and Breuer, R. (2002). Halofuginone does not reduce fibrosis in bleomycin- induced lung injury. Life Sci., 71, 1599-1606   DOI   ScienceOn
33 El Maghraoui, A., Chaouir, S., Abid, A., Bezza, A., Tabache, F., Achemlal, L., Abouzahir, A., Ghafir, D., Ohayon, V. and Archane, M.I. (2004). Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin. Rheumatol., 23, 123-128   DOI
34 Szapiel, S.V., Elson, N.A., Fulmer, J.D., Hunninghake, G.W. and Crystal, R.G. (1979). Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am. Rev. Respir. Dis., 120, 893-899
35 Flaherty, K.R. and Martinez, F.J. (2000). The role of pulmonary function testing in pulmonary fibrosis. Curr. Opin. Pulm. Med., 6, 404-410   DOI   ScienceOn
36 Lopez-Majano, V. and Renzi, G. (1978). Indications for pulmonary function testing. Respiration, 35, 53-63   DOI